Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
In this interactive case study, you will prepare for a tumor board discussion that will determine whether your patient is a candidate for biomarker testing and eligible for biomarker-directed therapy.
At ONS we recognize the pivotal role bispecific antibodies hold in enhancing patient care. We’re excited to share our latest video, which provides an introductory exploration into the realm of bispecific antibodies and their counterparts - natural antibodies, monoclonal antibodies, and antibody-drug conjugates.
The third edition of Telephone Triage for Oncology Nurses gives an updated look at this process, including new insights into patient care needs that result from newer cancer treatments, such as targeted and immunotherapies, as well as how updated technologies, including smartphones and Internet communication platforms, have enhanced patient assessment.
Explains the mechanism of action or CDK4/6 inhibitor, a targeted therapy used in the treatment of HR+, HER2- metastatic breast cancer.
After your patient is prescribed a CDK4/6 inhibitor, use this video to ensure that you have completed the appropriate initial assessment and tests.
Learn what to assess for prior to starting an oral agent and the signs of non-adherence.
Dr. Mahon provides an overview of germline testing and implications for nursing practice. She introduces the assessment findings that would lead to a referral to a genetics healthcare professional and the need of germline testing. She then reviews the possible outcomes of germline testing and what that interpretation means for the oncology nurse providing care to the patient.
Dr. Calzone provides an overview of the emerging use of paired somatic and germline testing to inform cancer treatment decisions. She will explain the science and clinical utility of this test along with the risks, benefits, and limitations. Throughout her presentation she will connect her content to the role of the oncology nurse and practice implications.